No Clear Winner In $4.3B Akorn Deal Row: Vice Chancellor
A Delaware vice chancellor warned Thursday that he saw no obvious winner in a battle over Fresenius Kabi AG's bid to walk away from a $4.3 billion deal to buy generic-drug...To view the full article, register now.
Already a subscriber? Click here to view full article